These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 27317738)

  • 21. Prognostic Factors Associated With Decreased Survival in Patients With Acinic Cell Carcinoma of the Parotid Gland.
    Liu Y; Su M; Yang Y; Zhao B; Qin L; Han Z
    J Oral Maxillofac Surg; 2017 Feb; 75(2):416-422. PubMed ID: 27474461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 20-Year Review of 75 Cases of Salivary Duct Carcinoma.
    Gilbert MR; Sharma A; Schmitt NC; Johnson JT; Ferris RL; Duvvuri U; Kim S
    JAMA Otolaryngol Head Neck Surg; 2016 May; 142(5):489-95. PubMed ID: 26939990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
    Chen CC; Wang L; Lin JC; Jan JS
    J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors and outcome analysis of submandibular gland cancer: a clinical audit.
    Mallik S; Agarwal J; Gupta T; Kane S; Laskar SG; Budrukkar A; Murthy V; Goel V; Jain S
    J Oral Maxillofac Surg; 2010 Sep; 68(9):2104-10. PubMed ID: 20538399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD24 expression predicts distant metastasis in extrahepatic bile duct cancer.
    Kim K; Min HS; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Jang JJ; Ha SW
    World J Gastroenterol; 2013 Mar; 19(9):1438-43. PubMed ID: 23539485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Parsimonious Prognostic Model and Heat Map for Predicting Survival Following Adjuvant Radiotherapy in Parotid Gland Carcinoma With Lymph Node Metastasis.
    Jiang WM; Wu LL; Wei HY; Ma QL; Zhang Q
    Technol Cancer Res Treat; 2021; 20():15330338211035257. PubMed ID: 34342241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer of the parotid gland; long-term follow-up. A single centre experience on recurrence and survival.
    Cederblad L; Johansson S; Enblad G; Engström M; Blomquist E
    Acta Oncol; 2009; 48(4):549-55. PubMed ID: 19140053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic variables in parotid gland cancer.
    Frankenthaler RA; Luna MA; Lee SS; Ang KK; Byers RM; Guillamondegui OM; Wolf P; Goepfert H
    Arch Otolaryngol Head Neck Surg; 1991 Nov; 117(11):1251-6. PubMed ID: 1747227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extramural perineural invasion in pT3 and pT4 rectal adenocarcinoma as prognostic factor after preoperative chemoradiotherapy.
    Lino-Silva LS; Salcedo-Hernández RA; España-Ferrufino A; Ruiz-García EB; Ruiz-Campos M; León-Takahashi AM; Meneses-García A
    Hum Pathol; 2017 Jul; 65():107-112. PubMed ID: 28526604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival in Patients with Primary Parotid Gland Carcinoma after Surgery-Results of a Single-Centre Study.
    Carta F; Bontempi M; De Seta D; Corrias S; Tatti M; Marrosu V; Mariani C; Gerosa C; Shetty SA; Atzeni M; Buckley C; Figus A; Puxeddu R
    Curr Oncol; 2023 Feb; 30(3):2702-2714. PubMed ID: 36975417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Outcome and prognostic factors of 125 loco-regionally advanced head and neck squamous cell carcinoma treated with multi-modality treatment].
    Qian W; Zhu G; Ji Q; Guo Y; Wang Y; Wang Y
    Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):217-22. PubMed ID: 24785284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
    Ma R; Zhang H; Zou L; Qu Y
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-Grade Salivary Gland Cancers: Treatment Outcomes, Extent of Surgery and Indications for Postoperative Adjuvant Radiation Therapy.
    Cho JK; Lim BW; Kim EH; Ko YH; Oh D; Noh JM; Ahn YC; Baek KH; Jeong HS
    Ann Surg Oncol; 2016 Dec; 23(13):4368-4375. PubMed ID: 27342828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraoperative radiotherapy for parotid cancer: a single-institution experience.
    Zeidan YH; Shiue K; Weed D; Johnstone PA; Terry C; Freeman S; Krowiak E; Borrowdale R; Huntley T; Yeh A
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1831-6. PubMed ID: 21514074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy of neutron radiation therapy in treating salivary gland malignancies.
    Timoshchuk MA; Dekker P; Hippe DS; Parvathaneni U; Liao JJ; Laramore GE; Dillon JK
    Oral Oncol; 2019 Jan; 88():51-57. PubMed ID: 30616797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of Patients Unable to Undergo Adjuvant Chemotherapy after Surgery in Stage IIIA/B Non-Small Cell Lung Cancer: Will They Benefit from Mediastinal Radiotherapy?
    Graeter TP; Sebastian B; Bischof M; Kugler G; Fischer JR; Schneider T
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):501-6. PubMed ID: 26322832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial.
    Chen QY; Wen YF; Guo L; Liu H; Huang PY; Mo HY; Li NW; Xiang YQ; Luo DH; Qiu F; Sun R; Deng MQ; Chen MY; Hua YJ; Guo X; Cao KJ; Hong MH; Qian CN; Mai HQ
    J Natl Cancer Inst; 2011 Dec; 103(23):1761-70. PubMed ID: 22056739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary squamous cell carcinoma of the parotid gland.
    Lee S; Kim GE; Park CS; Choi EC; Yang WI; Lee CG; Keum KC; Kim YB; Suh CO
    Am J Otolaryngol; 2001; 22(6):400-6. PubMed ID: 11713725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.